hypomagnesaemia

(redirected from hypomagnesaemic)

hypomagnesaemia

(ˌhaɪpəʊˌmæɡnəˈsiːmɪə) or

hypomagnesemia

n
(Veterinary Science) vet science the condition of having too little magnesium in the blood, particularly in cattle, in which it is also known as lactation tetany
Mentioned in ?
References in periodicals archive ?
18 mg/dL in hypomagnesaemic patients compared to 1.
A similar result was obtained by Sunil Kumar et al [11] in their study with the mean APACHE II score between hypomagnesaemic and normomagnesaemic group was 21.
A similar result was obtained by Safavi M et al, [12] who showed in their study that there was significant difference in ICU and hospital length of stay or mortality among the hypomagnesaemic and normomagnesaemic groups.
Proton pump inhibitors and hypomagnesaemic hypoparathyroidism.
The patients were stratified into three groups depending on their Mg level at admission: group A included hypomagnesaemic patients, group B included normomagnesaemic patients and group C included hypermagnesaemic patients.
Consequently, the hyper- and normomagnesaemic patients were grouped together and their mortality was compared with that of the hypomagnesaemic patients.
during Total Survivors, ICU stay patients, % (n) % (n) B1 Hypomagnesaemic * 3.
5l/min/m2) was statistically significantly more frequent in hypomagnesaemic patients (p less than 0.
Epidemiological studies linking hypertension and cardiovascular diseases with "soft water" and its protection by the use of "hard water", hypertensive patients who are hypomagnesaemic requiring greater number of antihypertensive medications, role of magnesium in pre-eclampsia are highlighted.
Hypomagnesaemic hypocalcaemia secondary to renal magnesium wasting occurred when large doses of gentamicin was given (14).
Hypomagnesaemic tetany associated with prolonged treatment with aminoglycoside has been reporeted (19) possibly due to excessive accumulation of aminolycoside in the kidney, 40 per cent of total body gentamycin (20) and also with the use of repeated courses of intravenous tobramycin in a patient with cystic fibrosis (21).